English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 11, 2026

Salk Institute scientists develop platform to study mitochondrial DNA mutations
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Study finds cholesterol-lowering drug reduces cardiac events in high-risk diabetes patients
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Study finds high rate of hypercortisolism in patients with resistant hypertension
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Study finds APOE4 affects brain immunity and cognition differently by sex
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Temporary heart pump before PCI shows no significant benefit
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Intensive LDL cholesterol lowering reduces cardiovascular events in heart disease patients
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Catheter-based approach improves prognosis in pulmonary embolism patients
+ Pharmaceuticals
Patient Daily | Apr 10, 2026

Investigational drug lowers angiotensinogen but shows unclear blood pressure benefits

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns